Eriks V. Krumkalns

The Adamantyl Group in Medicinal Agents. I. Hypoglycemic N-Arylsulfonyl-N'-adamantylureas

Koert Gerzon, Eriks V. Krumkalns, Richard L. Brindle et al. · Journal of Medicinal Chemistry · 1963 · 140 citations

Molecular Pharmacology, Medicinal Chemistry, Pharmaceutical Science +15

Estrogen synthetase inhibitors. 2. Comparison of the in vitro aromatase inhibitory activity for a variety of nitrogen heterocycles substituted with diarylmethane or diarylmethanol groups

C. David Jones, Mark A. Winter, Kenneth S. Hirsch et al. · Journal of Medicinal Chemistry · 1990 · 69 citations · Full text

Adamantyloxycarbonyl, a New Blocking Group. Preparation of 1-Adamantyl Chloroformate¹

Walter Haas, Eriks V. Krumkalns, Koert Gerzon · Journal of the American Chemical Society · 1966 · 62 citations

Biochemistry, Natural Sciences, Altmetric Attention Score +6

Structure-Activity Relationship of Some Diamine Bis-epoxides in Mouse Leukaemia

Koert Gerzon, James E. Cochran, Lawrence A. White et al. · Journal of Medicinal Chemistry · 1959 · 25 citations

Molecular Pharmacology, Therapeutic Drug Monitoring, Biochemistry +15

Adamantylamines by direct amination of 1-bromoadamantane

Eriks V. Krumkalns, William Pfeifer · Journal of Medicinal Chemistry · 1968 · 14 citations

Altmetrics, Enantioselective Synthesis, Direct Amination +15